Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics

References

• Avau B, Carbone F, Tack J, Depoortere I. Ghrelin signaling in the gut, its physiological properties, and therapeutic potential. Neurogastroenterol Motil. 2013;25(9):720–732. doi:10.1111/nmo.12193
   PubMed Web of Science ®Google Scholar
• Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114(1):57–66. doi:10.1172/JCI200421134
   PubMed Web of Science ®Google Scholar
• Guneli E, Kazikdas KC, Kolatan E. Ghrelin may attenuate proinflammatory cytokine-mediated neuropathic pain. Med Hypotheses. 2007;69(2):356–360. doi:10.1016/j.mehy.2006.12.042
   Web of Science ®Google Scholar
• Peng Z, Zha L, Yang M, Li Y, Guo X, Feng Z. Effects of ghrelin on pGSK-3beta and beta-catenin expression when protects against neuropathic pain behavior in rats challenged with chronic constriction injury. Sci Rep. 2019;9(1):14664. doi:10.1038/s41598-019-51140-w
   PubMed Web of Science ®Google Scholar
• Zhou CH, Li X, Zhu YZ, et al. Ghrelin alleviates neuropathic pain through GHSR-1a-mediated suppression of the p38 MAPK/NF-kappaB pathway in a rat chronic constriction injury model. Reg Anesth Pain Med. 2014;39(2):137–148. doi:10.1097/AAP.0000000000000050
   Web of Science ®Google Scholar
• Azizzadeh F, Mahmoodi J, Sadigh-Eteghad S, Farajdokht F, Mohaddes G. Ghrelin exerts analgesic effects through modulation of IL-10 and TGF-beta levels in a rat model of inflammatory pain. Iran Biomed J. 2017;21(2):114–119. doi:10.18869/acadpub.ibj.21.2.114
   Google Scholar
• Sibilia V, Lattuada N, Rapetti D, et al. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system. Neuropharmacology. 2006;51(3):497–505. doi:10.1016/j.neuropharm.2006.04.009
   Web of Science ®Google Scholar
• Sibilia V, Pagani F, Mrak E, Dieci E, Tulipano G, Ferrucci F. Pharmacological characterization of the ghrelin receptor mediating its inhibitory action on inflammatory pain in rats. Amino Acids. 2012;43(4):1751–1759. doi:10.1007/s00726-012-1260-8
   Web of Science ®Google Scholar
• Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990;98(5 Pt 1):1187–1192. doi:10.1016/0016-5085(90)90332-U
   PubMed Web of Science ®Google Scholar
• Poitras P, Riberdy Poitras M, Plourde V, Boivin M, Verrier P. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci. 2002;47(4):914–920. doi:10.1023/A:1014729125428
   Web of Science ®Google Scholar
• Sperber AD, Atzmon Y, Neumann L, et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol. 1999;94(12):3541–3546. doi:10.1111/j.1572-0241.1999.01643.x
   PubMed Web of Science ®Google Scholar
• Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol. 1991;30(3):220–222. doi:10.1093/rheumatology/30.3.220
   PubMedGoogle Scholar
• Yang TY, Chen CS, Lin CL, Lin WM, Kuo CN, Kao CH. Risk for irritable bowel syndrome in fibromyalgia patients: a national database study. Medicine (Baltimore). 2017;96(14):e6657. doi:10.1097/MD.0000000000006657
   Web of Science ®Google Scholar
• Chang L. Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder? Gastroenterol Clin North Am. 2005;34(2):271–279. doi:10.1016/j.gtc.2005.02.003
   PubMed Web of Science ®Google Scholar
• Zhou Q, Fillingim RB, Riley JL, Malarkey WB, Verne GN. Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain. 2010;148(3):454–461. doi:10.1016/j.pain.2009.12.005
   Web of Science ®Google Scholar
• Greenwood-van Meerveld B, Prusator DK, Johnson AC. Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol. 2015;308(11):G885–903. doi:10.1152/ajpgi.00463.2014
   Web of Science ®Google Scholar
• Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am J Physiol. 1997;273(1 Pt 1):G191–196. doi:10.1152/ajpgi.1997.273.1.G191
   Web of Science ®Google Scholar
• Gaudreau GA, Plourde V. Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat. Neurosci Lett. 2003;351(2):59–62. doi:10.1016/S0304-3940(03)00414-2
   Web of Science ®Google Scholar
• Greenwood-van Meerveld B, Johnson AC, Foreman RD, Linderoth B. Attenuation by spinal cord stimulation of a nociceptive reflex generated by colorectal distention in a rat model. Auton Neurosci. 2003;104(1):17–24. doi:10.1016/S1566-0702(02)00262-X
   Web of Science ®Google Scholar
• Karasawa H, Pietra C, Giuliano C, et al. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson’s disease. Neurogastroenterol Motil. 2014;26(12):1771–1782. doi:10.1111/nmo.12459
   PubMed Web of Science ®Google Scholar
• Venkova K, Mann W, Nelson R, Greenwood-van Meerveld B. Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus. J Pharmacol Exp Ther. 2009;329(3):1110–1116. doi:10.1124/jpet.108.149211
   Web of Science ®Google Scholar
• Jones RC, Otsuka E, Wagstrom E, Jensen CS, Price MP, Gebhart GF. Short-term sensitization of colon mechanoreceptors is associated with long-term hypersensitivity to colon distention in the mouse. Gastroenterology. 2007;133(1):184–194. doi:10.1053/j.gastro.2007.04.042
   PubMed Web of Science ®Google Scholar
• Myers B, Greenwood-van Meerveld B. Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol. 2007;292(6):G1622–1629. doi:10.1152/ajpgi.00080.2007
   Web of Science ®Google Scholar
• Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957;111(4):409–419.
   PubMedGoogle Scholar
• Johnson AC, Tran L, Greenwood-van Meerveld B. Knockdown of corticotropin-releasing factor in the central amygdala reverses persistent viscerosomatic hyperalgesia. Transl Psychiatry. 2015;5:e517. doi:10.1038/tp.2015.16
   Web of Science ®Google Scholar
• Greenwood-van Meerveld B, Tyler K, Mohammadi E, Pietra C. Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. J Exp Pharmacol. 2012;4:149–155. doi:10.2147/JEP.S35396
   Google Scholar
• Mohammadi EN, Pietra C, Giuliano C, Fugang L, Greenwood-van Meerveld B. A comparison of the central versus peripheral gastrointestinal prokinetic activity of two novel ghrelin mimetics. J Pharmacol Exp Ther. 2019;368(1):116–124. doi:10.1124/jpet.118.250738
   Web of Science ®Google Scholar
• Guneli E, Onal A, Ates M, et al. Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats. Neurosci Lett. 2010;479(3):226–230. doi:10.1016/j.neulet.2010.05.066
   Web of Science ®Google Scholar
• Wei J, Zhi X, Wang XL, et al. In vivo characterization of the effects of ghrelin on the modulation of acute pain at the supraspinal level in mice. Peptides. 2013;43:76–82. doi:10.1016/j.peptides.2013.03.004
   Web of Science ®Google Scholar
• Mao Y, Li Z, Chen K, et al. Antinociceptive effect of ghrelin in a rat model of irritable bowel syndrome involves TRPV1/opioid systems. Cell Physiol Biochem. 2017;43(2):518–530. doi:10.1159/000480478
   PubMedGoogle Scholar
• Cameron DM, Brennan TJ, Gebhart GF. Hind paw incision in the rat produces long-lasting colon hypersensitivity. J Pain. 2008;9(3):246–253. doi:10.1016/j.jpain.2007.10.017
   Web of Science ®Google Scholar
• Cervero F. Somatic and visceral inputs to the thoracic spinal cord of the cat: effects of noxious stimulation of the biliary system. J Physiol. 1983;337:51–67. doi:10.1113/jphysiol.1983.sp014611
   PubMed Web of Science ®Google Scholar
• Ness TJ, Gebhart GF. Interactions between visceral and cutaneous nociception in the rat. II. Noxious visceral stimuli inhibit cutaneous nociceptive neurons and reflexes. J Neurophysiol. 1991;66(1):29–39. doi:10.1152/jn.1991.66.1.29
   Web of Science ®Google Scholar
• Ness TJ, Gebhart GF. Interactions between visceral and cutaneous nociception in the rat. I. Noxious cutaneous stimuli inhibit visceral nociceptive neurons and reflexes. J Neurophysiol. 1991;66(1):20–28. doi:10.1152/jn.1991.66.1.20
   Web of Science ®Google Scholar
• Naitou K, Mamerto TP, Pustovit RV, et al. Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01. Neurogastroenterol Motil. 2015;27(12):1764–1771. doi:10.1111/nmo.12688
   Web of Science ®Google Scholar
• Ferrini F, Salio C, Lossi L, Merighi A. Ghrelin in central neurons. Curr Neuropharmacol. 2009;7(1):37–49. doi:10.2174/157015909787602779
   PubMed Web of Science ®Google Scholar
• Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol. 2006;494(3):528–548. doi:10.1002/cne.20823
   PubMed Web of Science ®Google Scholar
• Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561. doi:10.1530/eje.0.1390552
   Web of Science ®Google Scholar